Ketogenic diet for obesity: friend or foe?

Antonio Paoli, Antonio Paoli

Abstract

Obesity is reaching epidemic proportions and is a strong risk factor for a number of cardiovascular and metabolic disorders such as hypertension, type 2 diabetes, dyslipidemia, atherosclerosis, and also certain types of cancers. Despite the constant recommendations of health care organizations regarding the importance of weight control, this goal often fails. Genetic predisposition in combination with inactive lifestyles and high caloric intake leads to excessive weight gain. Even though there may be agreement about the concept that lifestyle changes affecting dietary habits and physical activity are essential to promote weight loss and weight control, the ideal amount and type of exercise and also the ideal diet are still under debate. For many years, nutritional intervention studies have been focused on reducing dietary fat with little positive results over the long-term. One of the most studied strategies in the recent years for weight loss is the ketogenic diet. Many studies have shown that this kind of nutritional approach has a solid physiological and biochemical basis and is able to induce effective weight loss along with improvement in several cardiovascular risk parameters. This review discusses the physiological basis of ketogenic diets and the rationale for their use in obesity, discussing the strengths and the weaknesses of these diets together with cautions that should be used in obese patients.

Figures

Figure 1
Figure 1
Ketone bodies: acetoacetate (AcAc) is the principle ketone body. It is produced and utilized during intermediary metabolism and other ketone bodies are derived from it. Acetone is produced by the spontaneous decarboxylation of acetoacetate and is important from the clinical point of view because it is responsible for the fruity sweet odour of infant ketoacidosis. β-Hydroxybutyric acid is produced via the reduction of AcAc. From a strictly biochemical point of view it is not actually a ketone body since the ketonic moiety is reduced to a hydroxyl group; it is though grouped among the ketone bodies. 3HB is relatively stable biochemically and is transported to the tissues where it is reconverted to AcAc.
Figure 2
Figure 2
Pathway of ketone bodies’ formation from acetyl-CoA.
Figure 3
Figure 3
Metabolic pathway of ketosis and tissues ketolysis.

References

    1. Olshansky S.J., Passaro D.J., Hershow R.C., Layden J., Carnes B.A., Brody J., Hayflick L., Butler R.N., Allison D.B., Ludwig D.S. A potential decline in life expectancy in the United States in the 21st century. N. Engl. J. Med. 2005;352:1138–1145. doi: 10.1056/NEJMsr043743.
    1. World Health Organization Obesity and Overweight, Factsheet No. 311, Updated March 2013. [(accessed on 24 January 2014)]. Available online:
    1. Koh-Banerjee P., Wang Y., Hu F.B., Spiegelman D., Willett W.C., Rimm E.B. Changes in bodyweight and body fat distribution as risk factors for clinical diabetes in US men. Amer. J. Epidemiol. 2004;159:1150–1159. doi: 10.1093/aje/kwh167.
    1. Thompson W.G., Cook D.A., Clark M.M., Bardia A., Levine J.A. Treatment of obesity. Mayo Clin. Proc. 2007;82:93–101.
    1. Paoli A., Moro T., Marcolin G., Neri M., Bianco A., Palma A., Grimaldi K. High-intensity interval resistance training (HIRT) influences resting energy expenditure and respiratory ratio in non-dieting individuals. J. Transl. Med. 2012;10:237. doi: 10.1186/1479-5876-10-237.
    1. Nordmann A.J., Nordmann A., Briel M., Keller U., Yancy W.S., Jr., Brehm B.J., Bucher H.C. Effects of low-carbohydrate vs. low-fat diets on weight loss and cardiovascular risk factors: A meta-analysis of randomized controlled trials. Arch. Intern. Med. 2006;166:285–293. doi: 10.1001/archinte.166.3.285.
    1. Chahoud G., Aude Y.W., Mehta J.L. Dietary recommendations in the prevention and treatment of coronary heart disease: Do we have the ideal diet yet? Amer. J. Cardiol. 2004;94:1260–1267. doi: 10.1016/j.amjcard.2004.07.109.
    1. Brehm B.J., Seeley R.J., Daniels S.R., D’Alessio D.A. A randomized trial comparing a very low carbohydrate diet and a calorie-restricted low fat diet on body weight and cardiovascular risk factors in healthy women. J. Clin. Endocrinol. Metab. 2003;88:1617–1623. doi: 10.1210/jc.2002-021480.
    1. Drewnowski A., Krahn D.D., Demitrack M.A., Nairn K., Gosnell B.A. Taste responses and preferences for sweet high-fat foods: Evidence for opioid involvement. Physiol. Behav. 1992;51:371–379. doi: 10.1016/0031-9384(92)90155-U.
    1. Yeomans M.R. Psychological approaches to under standing satiation and satiety. Agro Food Ind. Hi-Tech. 2010;21:16–19.
    1. Paoli A., Rubini A., Volek J.S., Grimaldi K.A. Beyond weight loss: A review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets. Eur. J. Clin. Nutr. 2013;67:789–796. doi: 10.1038/ejcn.2013.116.
    1. Kossoff E.H., Zupec-Kania B.A., Rho J.M. Ketogenic diets: An update for child neurologists. J. Child Neurol. 2009;24:979–988. doi: 10.1177/0883073809337162.
    1. Bueno N.B., de Melo I.S., de Oliveira S.L., da Rocha Ataide T. Very-low-carbohydrate ketogenic diet v. Low-fat diet for long-term weight loss: A meta-analysis of randomised controlled trials. Br. J. Nutr. 2013;110:1178–1187. doi: 10.1017/S0007114513000548.
    1. Al-Khalifa A., Mathew T.C., Al-Zaid N.S., Mathew E., Dashti H.M. Therapeutic role of low-carbohydrate ketogenic diet in diabetes. Nutrition. 2009;25:1177–1185. doi: 10.1016/j.nut.2009.04.004.
    1. Dashti H.M., Mathew T.C., Khadada M., Al-Mousawi M., Talib H., Asfar S.K., Behbahani A.I., Al-Zaid N.S. Beneficial effects of ketogenic diet in obese diabetic subjects. Mol. Cell. Biochem. 2007;302:249–256. doi: 10.1007/s11010-007-9448-z.
    1. Sharman M.J., Kraemer W.J., Love D.M., Avery N.G., Gomez A.L., Scheett T.P., Volek J.S. A ketogenic diet favorably affects serum biomarkers for cardiovascular disease in normal-weight men. J. Nutr. 2002;132:1879–1885.
    1. Freedman M.R., King J., Kennedy E. Popular diets: A scientific review. Obes. Res. 2001;9:S1–S40. doi: 10.1038/oby.2001.113.
    1. Krebs H.A. The regulation of the release of ketone bodies by the liver. Adv. Enzyme Regul. 1966;4:339–354. doi: 10.1016/0065-2571(66)90027-6.
    1. Felig P., Owen O.E., Wahren J., Cahill G.F., Jr. Amino acid metabolism during prolonged starvation. J. Clin. Invest. 1969;48:584–594. doi: 10.1172/JCI106017.
    1. Owen O.E. Ketone bodies as a fuel for the brain during starvation. Biochem. Mol. Biol. Educ. 2005;33:246–251. doi: 10.1002/bmb.2005.49403304246.
    1. Owen O.E., Felig P., Morgan A.P., Wahren J., Cahill G.F., Jr. Liver and kidney metabolism during prolonged starvation. J. Clin. Invest. 1969;48:574–583. doi: 10.1172/JCI106016.
    1. Owen O.E., Morgan A.P., Kemp H.G., Sullivan J.M., Herrera M.G., Cahill G.F., Jr. Brain metabolism during fasting. J. Clin. Invest. 1967;46:1589–1595. doi: 10.1172/JCI105650.
    1. Jitrapakdee S., Vidal-Puig A., Wallace J.C. Anaplerotic roles of pyruvate carboxylase in mammalian tissues. Cell. Mol. Life Sci. 2006;63:843–854. doi: 10.1007/s00018-005-5410-y.
    1. Hartman A.L., Gasior M., Vining E.P., Rogawski M.A. The neuropharmacology of the ketogenic diet. Pediatr. Neurol. 2007;36:281–292. doi: 10.1016/j.pediatrneurol.2007.02.008.
    1. Fukao T., Lopaschuk G.D., Mitchell G.A. Pathways and control of ketone body metabolism: On the fringe of lipid biochemistry. Prostaglandins Leukot. Essent. Fatty Acids. 2004;70:243–251. doi: 10.1016/j.plefa.2003.11.001.
    1. Laeger T., Metges C.C., Kuhla B. Role of beta-hydroxybutyric acid in the central regulation of energy balance. Appetite. 2010;54:450–455. doi: 10.1016/j.appet.2010.04.005.
    1. Veech R.L. The therapeutic implications of ketone bodies: The effects of ketone bodies in pathological conditions: Ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism. Prostaglandins Leukot. Essent. Fatty Acids. 2004;70:309–319. doi: 10.1016/j.plefa.2003.09.007.
    1. Leino R.L., Gerhart D.Z., Duelli R., Enerson B.E., Drewes L.R. Diet-induced ketosis increases monocarboxylate transporter (MCT1) levels in rat brain. Neurochem. Int. 2001;38:519–527. doi: 10.1016/S0197-0186(00)00102-9.
    1. Manninen A.H. Metabolic effects of the very-low-carbohydrate diets: Misunderstood “villains” of human metabolism. J. Int. Soc. Sport. Nutr. 2004;1:7–11. doi: 10.1186/1550-2783-1-2-7.
    1. McCue M.D. Starvation physiology: Reviewing the different strategies animals use to survive a common challenge. Comp. Biochem. Physiol. Pt. A. 2010;156:1–18. doi: 10.1016/j.cbpa.2010.01.002.
    1. Seyfried T.N., Mukherjee P. Targeting energy metabolism in brain cancer: Review and hypothesis. Nutr. Metab. 2005;2 doi: 10.1186/1743-7075-2-30.
    1. Vazquez J.A., Kazi U. Lipolysis and gluconeogenesis from glycerol during weight reduction with very-low-calorie diets. Metabolism. 1994;43:1293–1299. doi: 10.1016/0026-0495(94)90225-9.
    1. Veldhorst M.A., Westerterp-Plantenga M.S., Westerterp K.R. Gluconeogenesis and energy expenditure after a high-protein, carbohydrate-free diet. Amer. J. Clin. Nutr. 2009;90:519–526. doi: 10.3945/ajcn.2009.27834.
    1. Bortz W.M., Paul P., Haff A.C., Holmes W.L. Glycerol turnover and oxidation in man. J. Clin. Invest. 1972;51:1537–1546. doi: 10.1172/JCI106950.
    1. Paoli A., Grimaldi K., Toniolo L., Canato M., Bianco A., Fratter A. Nutrition and acne: Therapeutic potential of ketogenic diets. Skin Pharmacol. Physiol. 2012;25:111–117. doi: 10.1159/000336404.
    1. Atkins R.C. The High Calorie Way to Stay Thin Forever. D. McKay Co.; New York, NY, USA: 1972. Dr. Atkins’ Diet Revolution.
    1. Feinman R.D., Fine E.J. Nonequilibrium thermodynamics and energy efficiency in weight loss diets. Theor. Biol. Med. Model. 2007;4 doi: 10.1186/1742-4682-4-27.
    1. Westerterp-Plantenga M.S., Nieuwenhuizen A., Tome D., Soenen S., Westerterp K.R. Dietary protein, weight loss, and weight maintenance. Annu. Rev. Nutr. 2009;29:21–41. doi: 10.1146/annurev-nutr-080508-141056.
    1. Paoli A., Grimaldi K., Bianco A., Lodi A., Cenci L., Parmagnani A. Medium term effects of a ketogenic diet and a mediterranean diet on resting energy expenditure and respiratory ratio. BMC Proc. 2012;6 doi: 10.1186/1753-6561-6-S3-P37.
    1. Veldhorst M., Smeets A., Soenen S., Hochstenbach-Waelen A., Hursel R., Diepvens K., Lejeune M., Luscombe-Marsh N., Westerterp-Plantenga M. Protein-induced satiety: Effects and mechanisms of different proteins. Physiol. Behav. 2008;94:300–307. doi: 10.1016/j.physbeh.2008.01.003.
    1. Sumithran P., Prendergast L.A., Delbridge E., Purcell K., Shulkes A., Kriketos A., Proietto J. Ketosis and appetite-mediating nutrients and hormones after weight loss. Eur. J. Clin. Nutr. 2013;67:759–764. doi: 10.1038/ejcn.2013.90.
    1. Johnstone A.M., Horgan G.W., Murison S.D., Bremner D.M., Lobley G.E. Effects of a high-protein ketogenic diet on hunger, appetite, and weight loss in obese men feeding ad libitum. Amer. J. Clin. Nutr. 2008;87:44–55.
    1. Cahill G.F., Jr. Fuel metabolism in starvation. Annu. Rev. Nutr. 2006;26:1–22. doi: 10.1146/annurev.nutr.26.061505.111258.
    1. Paoli A., Cenci L., Fancelli M., Parmagnani A., Fratter A., Cucchi A., Bianco A. Ketogenic diet and phytoextracts comparison of the efficacy of mediterranean, zone and tisanoreica diet on some health risk factors. Agro Food Ind. Hi-Tech. 2010;21:24–29.
    1. Tagliabue A., Bertoli S., Trentani C., Borrelli P., Veggiotti P. Effects of the ketogenic diet on nutritional status, resting energy expenditure, and substrate oxidation in patients with medically refractory epilepsy: A 6-month prospective observational study. Clin. Nutr. 2012;31:246–249. doi: 10.1016/j.clnu.2011.09.012.
    1. Fine E.J., Feinman R.D. Thermodynamics of weight loss diets. Nutr. Metab. 2004;1 doi: 10.1186/1743-7075-1-15.
    1. Davidson T.L., Hargrave S.L., Swithers S.E., Sample C.H., Fu X., Kinzig K.P., Zheng W. Inter-relationships among diet, obesity and hippocampal-dependent cognitive function. Neuroscience. 2013;253:110–122. doi: 10.1016/j.neuroscience.2013.08.044.
    1. Brinkworth G.D., Noakes M., Clifton P.M., Buckley J.D. Effects of a low carbohydrate weight loss diet on exercise capacity and tolerance in obese subjects. Obesity. 2009;17:1916–1923. doi: 10.1038/oby.2009.134.
    1. Yancy W.S., Jr., Almirall D., Maciejewski M.L., Kolotkin R.L., McDuffie J.R., Westman E.C. Effects of two weight-loss diets on health-related quality of life. Qual. Life Res. 2009;18:281–289. doi: 10.1007/s11136-009-9444-8.
    1. Vining E.P., Freeman J.M., Ballaban-Gil K., Camfield C.S., Camfield P.R., Holmes G.L., Shinnar S., Shuman R., Trevathan E., Wheless J.W. A multicenter study of the efficacy of the ketogenic diet. Arch. Neurol. 1998;55:1433–1437. doi: 10.1001/archneur.55.11.1433.
    1. Lefevre F., Aronson N. Ketogenic diet for the treatment of refractory epilepsy in children: A systematic review of efficacy. [(accessed on 14 February 2014)];Pediatrics. 2000 105:e46. Available online: .
    1. McLaughlin T., Allison G., Abbasi F., Lamendola C., Reaven G. Prevalence of insulin resistance and associated cardiovascular disease risk factors among normal weight, overweight, and obese individuals. Metabolism. 2004;53:495–499. doi: 10.1016/j.metabol.2003.10.032.
    1. Rabinowitz D., Zierler K.L. Forearm metabolism in obesity and its response to intra-arterial insulin. Characterization of insulin resistance and evidence for adaptive hyperinsulinism. J. Clin. Invest. 1962;41:2173–2181. doi: 10.1172/JCI104676.
    1. Volek J.S., Phinney S.D., Forsythe C.E., Quann E.E., Wood R.J., Puglisi M.J., Kraemer W.J., Bibus D.M., Fernandez M.L., Feinman R.D. Carbohydrate restriction has a more favorable impact on the metabolic syndrome than a low fat diet. Lipids. 2009;44:297–309. doi: 10.1007/s11745-008-3274-2.
    1. McDaniel S.S., Rensing N.R., Thio L.L., Yamada K.A., Wong M. The ketogenic diet inhibits the mammalian target of rapamycin (mTOR) pathway. Epilepsia. 2011;52 doi: 10.1111/j.1528-1167.2011.02981.x.
    1. Freedland S.J., Mavropoulos J., Wang A., Darshan M., Demark-Wahnefried W., Aronson W.J., Cohen P., Hwang D., Peterson B., Fields T., et al. Carbohydrate restriction, prostate cancer growth, and the insulin-like growth factor axis. Prostate. 2008;68:11–19. doi: 10.1002/pros.20683.
    1. Srivastava S., Kashiwaya Y., King M.T., Baxa U., Tam J., Niu G., Chen X., Clarke K., Veech R.L. Mitochondrial biogenesis and increased uncoupling protein 1 in brown adipose tissue of mice fed a ketone ester diet. FASEB J. 2012;26:2351–2362. doi: 10.1096/fj.11-200410.
    1. Chang K.T., Min K.T. Regulation of lifespan by histone deacetylase. Ageing Res. Rev. 2002;1:313–326. doi: 10.1016/S1568-1637(02)00003-X.
    1. Yoo Y.E., Ko C.P. Treatment with trichostatin a initiated after disease onset delays disease progression and increases survival in a mouse model of amyotrophic lateral sclerosis. Exp. Neurol. 2011;231:147–159. doi: 10.1016/j.expneurol.2011.06.003.
    1. Kang H.L., Benzer S., Min K.T. Life extension in drosophila by feeding a drug. Proc. Natl. Acad. Sci. USA. 2002;99:838–843. doi: 10.1073/pnas.022631999.
    1. Mammucari C., Schiaffino S., Sandri M. Downstream of Akt: Foxo3 and mTOR in the regulation of autophagy in skeletal muscle. Autophagy. 2008;4:524–526.
    1. Sandri M. Signaling in muscle atrophy and hypertrophy. Physiology. 2008;23:160–170. doi: 10.1152/physiol.00041.2007.
    1. Sandri M., Barberi L., Bijlsma A.Y., Blaauw B., Dyar K.A., Milan G., Mammucari C., Meskers C.G., Pallafacchina G., Paoli A., et al. Signalling pathways regulating muscle mass in ageing skeletal muscle. The role of the IGF1-Akt-mTOR-FoxO pathway. Biogerontology. 2013;14:303–323. doi: 10.1007/s10522-013-9432-9.
    1. Janda M., Zeidler D., Bohm G., Schoberberger R. An instrument to measure adherence to weight loss programs: The compliance praxis survey-diet (COMPASS-diet) Nutrients. 2013;5:3828–3838. doi: 10.3390/nu5103828.
    1. Jeffery R.W. Does weight cycling present a health risk? Amer. J. Clin. Nutr. 1996;63:S452–S455.
    1. Sumithran P., Proietto J. The defence of body weight: A physiological basis for weight regain after weight loss. Clin. Sci. 2013;124:231–241. doi: 10.1042/CS20120223.
    1. Wing R.R., Hill J.O. Successful weight loss maintenance. Annu. Rev. Nutr. 2001;21:323–341. doi: 10.1146/annurev.nutr.21.1.323.
    1. Thomas P.R. Weighing the Options: Criteria for Evaluating Weight-Management Programs. National Academies Press; Washington, DC, USA: 1995.
    1. Paoli A., Bianco A., Grimaldi K.A., Lodi A., Bosco G. Long term successful weight loss with a combination biphasic ketogenic mediterranean diet and mediterranean diet maintenance protocol. Nutrients. 2013;5:5205–5217. doi: 10.3390/nu5125205.
    1. Volek J.S., Sharman M.J., Forsythe C.E. Modification of lipoproteins by very low-carbohydrate diets. J. Nutr. 2005;135:1339–1342.
    1. Welle S., Nair K.S. Relationship of resting metabolic rate to body composition and protein turnover. Amer. J. Physiol. 1990;258:990–998.
    1. Praga M. Synergy of low nephron number and obesity: A new focus on hyperfiltration nephropathy. Nephrol. Dial. Transplant. 2005;20:2594–2597. doi: 10.1093/ndt/gfi201.
    1. Westerterp-Plantenga M.S. How are normal, high- or low-protein diets defined? Br. J. Nutr. 2007;97:217–218. doi: 10.1017/S0007114507381348.
    1. Eisenstein J., Roberts S.B., Dallal G., Saltzman E. High-protein weight-loss diets: Are they safe and do they work? A review of the experimental and epidemiologic data. Nutr. Rev. 2002;60:189–200. doi: 10.1301/00296640260184264.
    1. Pijls L.T., de Vries H., Donker A.J., van Eijk J.T. The effect of protein restriction on albuminuria in patients with type 2 diabetes mellitus: A randomized trial. Nephrol. Dial. Transplant. 1999;14:1445–1453. doi: 10.1093/ndt/14.6.1445.
    1. Pijls L.T., de Vries H., van Eijk J.T., Donker A.J. Protein restriction, glomerular filtration rate and albuminuria in patients with type 2 diabetes mellitus: A randomized trial. Eur. J. Clin. Nutr. 2002;56:1200–1207. doi: 10.1038/sj.ejcn.1601474.
    1. Poplawski M.M., Mastaitis J.W., Isoda F., Grosjean F., Zheng F., Mobbs C.V. Reversal of diabetic nephropathy by a ketogenic diet. PLoS One. 2011;6 doi: 10.1371/journal.pone.0018604.
    1. Paoli A., Cenci L., Grimaldi K.A. Effect of ketogenic mediterranean diet with phytoextracts and low carbohydrates/high-protein meals on weight, cardiovascular risk factors, body composition and diet compliance in Italian council employees. Nutr. J. 2011;10 doi: 10.1186/1475-2891-10-112.
    1. Paoli A., Grimaldi K., D’Agostino D., Cenci L., Moro T., Bianco A., Palma A. Ketogenic diet does not affect strength performance in elite artistic gymnasts. J. Int. Soc. Sports Nutr. 2012;9 doi: 10.1186/1550-2783-9-34.
    1. Paoli A., Canato M., Toniolo L., Bargossi A.M., Neri M., Mediati M., Alesso D., Sanna G., Grimaldi K.A., Fazzari A.L., et al. The ketogenic diet: An underappreciated therapeutic option? Clin. Ter. 2011;162:145–153.
    1. Noto H., Goto A., Tsujimoto T., Noda M. Low-carbohydrate diets and all-cause mortality: A systematic review and meta-analysis of observational studies. PLoS One. 2013;8 doi: 10.1371/journal.pone.0055030.
    1. Larsen T.M., Dalskov S.M., van Baak M., Jebb S.A., Papadaki A., Pfeiffer A.F., Martinez J.A., Handjieva-Darlenska T., Kunesova M., Pihlsgard M., et al. Diets with high or low protein content and glycemic index for weight-loss maintenance. N. Engl. J. Med. 2010;363:2102–2113. doi: 10.1056/NEJMoa1007137.
    1. Bielohuby M., Sisley S., Sandoval D., Herbach N., Zengin A., Fischereder M., Menhofer D., Stoehr B.J., Stemmer K., Wanke R., et al. Impaired glucose tolerance in rats fed low-carbohydrate, high-fat diets. Am. J. Physiol. Endocrinol. Metab. 2013;305:1059–1070. doi: 10.1152/ajpendo.00208.2013.
    1. Ellenbroek J.H., van Dijck L., Tons H.A., Rabelink T.J., Carlotti F., Ballieux B.E., de Koning E.J. Long-term ketogenic diet causes glucose intolerance and reduced beta and alpha cell mass but no weight loss in mice. Am. J. Physiol. Endocrinol. Metab. 2014 doi: 10.1152/ajpendo.00453.2013.
    1. Bielohuby M., Menhofer D., Kirchner H., Stoehr B.J., Muller T.D., Stock P., Hempel M., Stemmer K., Pfluger P.T., Kienzle E., et al. Induction of ketosis in rats fed low-carbohydrate, high-fat diets depends on the relative abundance of dietary fat and protein. Am. J. Physiol. Endocrinol. Metab. 2011;300:65–76. doi: 10.1152/ajpendo.00478.2010.
    1. Demetrius L. Aging in mouse and human systems: A comparative study. Ann. N. Y. Acad. Sci. 2006;1067:66–82.
    1. Demetrius L. Of mice and men. When it comes to studying ageing and the means to slow it down, mice are not just small humans. EMBO Rep. 2005;6:S39–S44. doi: 10.1038/sj.embor.7400422.
    1. Bielohuby M., Sawitzky M., Stoehr B.J., Stock P., Menhofer D., Ebensing S., Bjerre M., Frystyk J., Binder G., Strasburger C., et al. Lack of dietary carbohydrates induces hepatic growth hormone (GH) resistance in rats. Endocrinology. 2011;152:1948–1960. doi: 10.1210/en.2010-1423.
    1. Bielohuby M., Matsuura M., Herbach N., Kienzle E., Slawik M., Hoeflich A., Bidlingmaier M. Short-term exposure to low-carbohydrate, high-fat diets induces low bone mineral density and reduces bone formation in rats. J. Bone Miner. Res. 2010;25:275–284. doi: 10.1359/jbmr.090813.
    1. Bergqvist A.G., Schall J.I., Stallings V.A., Zemel B.S. Progressive bone mineral content loss in children with intractable epilepsy treated with the ketogenic diet. Amer. J. Clin. Nutr. 2008;88:1678–1684. doi: 10.3945/ajcn.2008.26099.
    1. Gower B.A., Casazza K. Divergent effects of obesity on bone health. J. Clin. Densitom. 2013;16:450–454. doi: 10.1016/j.jocd.2013.08.010.
    1. Clifton P. Effects of a high protein diet on body weight and comorbidities associated with obesity. Br. J. Nutr. 2012;108:S122–S129. doi: 10.1017/S0007114512002322.
    1. Tang M., O’Connor L.E., Campbell W.W. Diet-induced weight loss: The effect of dietary protein on bone. J. Acad. Nutr. Diet. 2014;114:72–85. doi: 10.1016/j.jand.2013.08.021.
    1. Carter J.D., Vasey F.B., Valeriano J. The effect of a low-carbohydrate diet on bone turnover. Osteoporos. Int. 2006;17:1398–1403. doi: 10.1007/s00198-006-0134-x.
    1. Skov A.R., Haulrik N., Toubro S., Molgaard C., Astrup A. Effect of protein intake on bone mineralization during weight loss: A 6-month trial. Obes. Res. 2002;10:432–438. doi: 10.1038/oby.2002.60.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj